Aurora Cannabis Inc. (ACB.TO)
| Previous close | 0.9100 |
| Open | 0.9100 |
| Bid | 0.9200 x 0 |
| Ask | 0.9400 x 0 |
| Day's range | 0.9100 - 0.9400 |
| 52-week range | 0.8900 - 5.6500 |
| Volume | |
| Avg. volume | 1,146,568 |
| Market cap | 320.528M |
| Beta (5Y monthly) | 3.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.5100 |
| Earnings date | 10 May 2023 - 15 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.78 |
- Motley Fool
2 Reasons to Buy Aurora Cannabis and 1 Reason to Sell It
Aurora Cannabis (NASDAQ: ACB) is one of the few Canadian cannabis retailers that is still seeing revenue growth, despite price compression and illegal sales negatively impacting the industry. The company is still losing money, but it appears to be edging its way toward profitability. Aurora's path to success includes branching out to international markets while focusing more on medical marijuana sales at home.
- Motley Fool
Why Pot Stocks Are Glowing Green Today
With fears of economic turbulence receding, Aurora Cannabis, Canopy Growth, and Organigram rebounded from their Monday declines.
- Motley Fool
Here's How Aurora Cannabis Finally Posted an Adjusted EBITDA Profit
Aurora Cannabis (NASDAQ: ACB) hit a long-awaited milestone in its most recent earnings results: adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) profitability. Here's a closer look at how Aurora achieved an adjusted EBITDA profit, and whether that should impact your decision to buy the stock or not. Since it's a non-GAAP (adjusted) number, a company can make adjustments to that number that it otherwise wouldn't be able to make to net income.
